Cardiox Liver Function Test Pivotal Trial
NCT02552901
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Hepatic Failure
Liver Failure
Interventions
DRUG:
0.1 mg/kg ICG Dose
DRUG:
0.5 mg/kg ICG dose
Sponsor
Cardiox Corporation